daunorubicin citrate liposome - injection, Daunoxome
GENERIC NAME: DAUNORUBICIN CITRATE LIPOSOME - INJECTION (dawn-oh-REWB-eh-sin SIH-trate lye-poe-SEW-mull)
BRAND NAME(S): Daunoxome
WARNING: This medication may infrequently result in serious (rarely fatal) heart problems (including heart failure). This may occur both during treatment or months to years after treatment is completed. The risk of heart problems is affected by your dose, medical history (including previous heart disease, radiation treatment to the chest area), and previous use of this and other drugs (including doxorubicin). Tell your doctor immediately if you notice symptoms such as very fast/irregular heartbeat, shortness of breath, or swelling ankles/feet.
Daunorubicin may cause certain severe blood and bone marrow disorders (low red blood cells/white blood cells/platelets). This can affect your body's ability to stop bleeding or fight infection. Tell your doctor immediately if you develop easy bleeding/bruising or signs of infection (e.g., fever, chills, persistent sore throat).
Very rarely, people with cancer who are treated with this type of medication have developed other cancers (e.g., secondary leukemia). The risk may be increased when this medication is given with certain anti-cancer drugs or radiation treatment. Consult your doctor for more details.
Before starting treatment with this medication, tell your doctor if you have liver or kidney problems. Your dose may need to be adjusted.
This medication may cause symptoms including back pain, flushing, and chest tightness, usually during the first 5 minutes of injection into a vein. If you notice any of these symptoms, tell your doctor or nurse immediately. If the injection is temporarily stopped and then given more slowly, the symptoms will not usually return.
Back to Medications Index
Get the latest health and medical information delivered direct to your inbox FREE!